FIELD: medicine.
SUBSTANCE: as additional components, a new medicinal form contains stearic acid or its pharmaceutically acceptable salt, succinic acid or its pharmaceutically acceptable salt, microcrystalline cellulose, magnesium carbonate, starch and hydroxypropyl cellulose.
EFFECT: extended range of storage-stable preparations of 3-oxy-6-methyl-2-ethylpyridine as solid oral dosage forms without by-effects of existing preparations.
14 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID INDIVIDUAL HIGH 2-ETHYL-6-METHYL-3-PYRIDIN-3-OLE HYDROCHLORIDE DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2448686C1 |
| PHARMACEUTICAL COMPOSITION WITH 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE FOR ORAL ADMINISTRATION AND METHOD FOR PREPARING IT | 2010 |
|
RU2444359C1 |
| ANTIDIABETIC PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING | 1999 |
|
RU2233659C2 |
| COMBINATION OF MIRTAZAPINE AND TIZANIDINE FOR USE IN PAIN DISORDERS | 2019 |
|
RU2736713C1 |
| MODIFIED RELEASE 6-METHYL-2-ETHYL-HYDROXYPYRIDINE SUCCINATE DOSAGE FORM | 2008 |
|
RU2411035C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING A BICYCLO-SUBSTITUTED AZO DERIVATIVE OF PYRAZOLONE OR A SALT THEREOF, AND A METHOD FOR PRODUCTION THEREOF | 2017 |
|
RU2733844C2 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTIMICROBIAL ACTION, AND METHOD FOR PREPARING IT | 2012 |
|
RU2497501C1 |
| PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION CONTAINING GLUCOKINASE ACTIVATOR AND BIGUANIDE HYPOGLYCEMIC DRUG, AS WELL AS THEIR PREPARATION METHOD, AND THEIR USE | 2019 |
|
RU2780377C2 |
| SOLID PHARMACEUTICAL COMPOSITION FOR IMPROVEMENT OF MAIL ERECTILITY FUNCTION | 2005 |
|
RU2283650C1 |
| SOLID MEDICATION | 2003 |
|
RU2357757C2 |
